ArticleParasites & vectors2026
Vector-borne pathogen profiling and phylogeny of ticks infesting domestic dogs in Chad, Africa, using targeted next-generation sequencing and DNA barcoding.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnderstanding the range of vectors and pathogen diversity in sub-Saharan Africa is crucial for efficient disease prevention and control efforts. Domestic dogs are susceptible to many vector-borne pathogens (VBPs) and serve as sentinels for several human pathogens. Yet, critical surveillance gaps in canine VBPs persist in Central Africa, where the tropical climate and pastoral agro-livelihoods create unique transmission risks.
methodsWe conducted a cross-sectional survey from September to October 2021, collecting 4238 ticks from 1254 domestic dogs across 56 villages in Chad, Africa. All ticks were identified morphologically and/or by sequence analysis of 16S rDNA, 12S rDNA, and cytochrome c oxidase subunit I (COI) gene regions. A representative subset (n = 618) was subsequently screened for comprehensive, simultaneous detection of 21 VBPs using a targeted next-generation sequencing (tNGS) assay. Logistic regression models were used to assess associations between potential risk factors and pathogen detection.
resultsFive tick species belonging to four genera were identified: Rhipicephalus linnaei (89.8%; 3805/4238), Rhipicephalus muhsamae (9.4%; 400/4238), Amblyomma variegatum (0.6%; 26/4238), Haemaphysalis leachi (0.1%; 4/4238), and Hyalomma truncatum (0.1%; 3/4238). Overall, 59.1% (365/618; 95% CI 55.1 - 62.9%) of the ticks were positive for at least one pathogen. We detected 14 pathogens, with the most prevalent being Hepatozoon canis (47.6%, n = 294/618), followed by Ehrlichia canis (8.4%, n = 52/618), Coxiella-like endosymbionts (5.3%, n = 33/618), Rickettsia spp. (4.7%, n = 29/618), Anaplasma platys (4.4%, n = 27/618), Anaplasma spp. (3.7%, n = 23/618), hemotropic Mycoplasma spp. (1.5%, n = 9/618), and Anaplasma phagocytophilum (1.1%, n = 7/618). Babesia caballi, Hepatozoon felis, Rickettsia conorii, and Rickettsia massiliae were each identified in < 1% of the ticks. The highest pathogen diversity was detected in R. linnaei, although R. muhsamae harbored the highest diversity of zoonotic Rickettsia species. Independent predictors for VBP infections included tick species for E. canis (P = 0.02) and H. canis (P = 0.001), and geographic region for E. canis (P = 0.01). CONCLUSIONS/SIGNIFICANCE: This study provides a comprehensive molecular characterization of canine VBPs in ticks from Central Africa using deep sequencing. The high pathogen prevalence and diversity highlight the need for expanded surveillance and control strategies in Chad, including educating dog owners on ectoparasite prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.